Showing results (631-640 of 726) with videos related to
Sort By:
Pageof 73
Proceedings (Baylor University. Medical Center)|July 18, 2020
Usefulness of patient-reported outcomes to assess the effectiveness of topical hormonal therapy for gynecologic symptoms after antihormonal treatment for breast cancerAmit L Jain, Omer Jamy, Janice Mullins, et al.The Lancet. Oncology|February 11, 2024
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trialCarlo Palmieri, Hannah Linden, Stephen N Birrell, et al.British Journal of Cancer|April 20, 2001
A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapyJ Glaspy, J S Jadeja, G Justice, et al.American Journal of Clinical Oncology|October 22, 1998
Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centersL S Schwartzberg, R Birch, W H West, et al.Immunity|March 23, 2011
Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alphaJason A Hall, Jennifer L Cannons, John R Grainger, et al.Elife|October 31, 2019
Transient protein accumulation at the center of the T cell antigen-presenting cell interface drives efficient IL-2 secretionDanielle J Clark, Laura E McMillan, Sin Lih Tan, et al.Nature Communications|February 11, 2022
In vivo CRISPR screens reveal a HIF-1α-mTOR-network regulates T follicular helper versus Th1 cellsBonnie Huang, James D Phelan, Silvia Preite, et al.Breast Cancer Research and Treatment|February 9, 2017
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I studyM Higgins, G Curigliano, V Dieras, et al.Biorxiv : the Preprint Server for Biology|March 31, 2025
Sulfide is a keystone metabolite for gut homeostasis and immunityVictor I Band, Inta Gribonika, Apollo Stacy, et al.Planta|June 16, 2009
Label-free in situ imaging of lignification in the cell wall of low lignin transgenic Populus trichocarpaM Schmidt, A M Schwartzberg, P N Perera, et al.Pageof 73